2022 annual financial data
Unicycive Therapeutics 2022 Operating margin
Direct answer
Operating margin was -1,898.21%.
Operating income was -18,052,000 USD and net income was -18,064,000 USD.
Operating cash flow was -15,651,000 USD.
Get free Unicycive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 951,000 USD
- Operating income
- -18,052,000 USD
- Net income
- -18,064,000 USD
- Operating cash flow
- -15,651,000 USD